Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
PROV vs HOMB vs WAFD vs CVBF vs BANR vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Diversified
PROV vs HOMB vs WAFD vs CVBF vs BANR vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||||
|---|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $109M | $5.58B | $2.85B | $2.88B | $2.28B | $896.00B |
| Revenue (TTM) | $60M | $1.37B | $1.39B | $644M | $819M | $280.33B |
| Net Income (TTM) | $7M | $475M | $243M | $209M | $195M | $57.05B |
| Gross Margin | 67.8% | 77.3% | 52.8% | 79.7% | 79.0% | 60.0% |
| Operating Margin | 16.2% | 43.8% | 22.4% | 43.7% | 29.5% | 25.9% |
| Forward P/E | 15.4x | 11.5x | 11.4x | 14.7x | 10.9x | 14.4x |
| Total Debt | $213M | $935M | $1.82B | $991M | $373M | $942.38B |
| Cash & Equiv. | $53M | $667M | $657M | $108M | $183M | $343.34B |
PROV vs HOMB vs WAFD vs CVBF vs BANR vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Provident Financial… (PROV) | 100 | 127.6 | +27.6% |
| Home Bancshares, In… (HOMB) | 100 | 183.7 | +83.7% |
| WaFd, Inc. (WAFD) | 100 | 138.1 | +38.1% |
| CVB Financial Corp. (CVBF) | 100 | 113.3 | +13.3% |
| Banner Corporation (BANR) | 100 | 176.9 | +76.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PROV vs HOMB vs WAFD vs CVBF vs BANR vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PROV ranks third and is worth considering specifically for income & stability and defensive.
- Dividend streak 0 yrs, beta 0.21, yield 3.3%
- Beta 0.21, yield 3.3%, current ratio 0.06x
- Beta 0.21 vs JPM's 0.94, lower leverage
HOMB is the clearest fit if your priority is sleep-well-at-night and bank quality.
- Lower volatility, beta 0.66, Low D/E 21.8%, current ratio 0.13x
- NIM 3.8% vs JPM's 2.2%
WAFD carries the broadest edge in this set and is the clearest fit for quality and momentum.
- Efficiency ratio 0.3% vs PROV's 0.5% (lower = leaner)
- +32.5% vs HOMB's +3.0%
- Efficiency ratio 0.3% vs PROV's 0.5%
CVBF is the clearest fit if your priority is dividends.
- 3.8% yield, vs WAFD's 2.8%
BANR doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
JPM is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 3.3%, EPS growth 1.5%
- 465.8% 10Y total return vs BANR's 101.5%
- PEG 0.81 vs CVBF's 4.64
- 3.3% NII/revenue growth vs HOMB's -5.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.3% NII/revenue growth vs HOMB's -5.3% | |
| Value | Lower P/E (14.4x vs 14.7x), PEG 0.81 vs 4.64 | |
| Quality / Margins | Efficiency ratio 0.3% vs PROV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.21 vs JPM's 0.94, lower leverage | |
| Dividends | 3.8% yield, vs WAFD's 2.8% | |
| Momentum (1Y) | +32.5% vs HOMB's +3.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs PROV's 0.5% |
PROV vs HOMB vs WAFD vs CVBF vs BANR vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PROV vs HOMB vs WAFD vs CVBF vs BANR vs JPM — Financial Metrics
Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HOMB leads in 3 of 6 categories
JPM leads 1 • PROV leads 0 • WAFD leads 0 • CVBF leads 0 • BANR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HOMB leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. HOMB is the more profitable business, keeping 34.6% of every revenue dollar as net income compared to PROV's 11.0%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $60M | $1.4B | $1.4B | $644M | $819M | $280.3B |
| EBITDAEarnings before interest/tax | $12M | $618M | $277M | $294M | $253M | $81.4B |
| Net IncomeAfter-tax profit | $7M | $475M | $243M | $209M | $195M | $57.0B |
| Free Cash FlowCash after capex | $9M | $311M | $215M | $217M | $248M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +67.8% | +77.3% | +52.8% | +79.7% | +79.0% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +16.2% | +43.8% | +22.4% | +43.7% | +29.5% | +25.9% |
| Net MarginNet income ÷ Revenue | +11.0% | +34.6% | +17.5% | +32.5% | +23.8% | +20.4% |
| FCF MarginFCF ÷ Revenue | +15.3% | +22.6% | +15.5% | +33.7% | +30.3% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +69.2% | +26.0% | +46.3% | +11.1% | +11.2% | +16.0% |
Valuation Metrics
HOMB leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 11.7x trailing earnings, HOMB trades at a 36% valuation discount to PROV's 18.4x P/E. Adjusting for growth (PEG ratio), HOMB offers better value at 0.89x vs WAFD's 4.58x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Market CapShares × price | $109M | $5.6B | $2.9B | $2.9B | $2.3B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $269M | $5.9B | $4.0B | $3.8B | $2.5B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 18.40x | 11.72x | 14.10x | 13.97x | 11.92x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.41x | 11.47x | 11.35x | 14.74x | 10.92x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.89x | 4.58x | 4.40x | 1.03x | 0.90x |
| EV / EBITDAEnterprise value multiple | 21.77x | 9.47x | 13.41x | 13.37x | 9.77x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 4.06x | 2.02x | 4.48x | 2.78x | 3.20x |
| Price / BookPrice ÷ Book value/share | 0.90x | 1.30x | 0.98x | 1.26x | 1.19x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 13.38x | 11.58x | 13.71x | 13.26x | 9.19x | 8.88x |
Profitability & Efficiency
HOMB leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $5 for PROV. BANR carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), WAFD scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | ||||||
|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +11.4% | +8.0% | +9.3% | +10.3% | +15.9% |
| ROA (TTM)Return on assets | +0.5% | +2.1% | +0.9% | +1.4% | +1.2% | +1.3% |
| ROICReturn on invested capital | +1.9% | +8.7% | +3.9% | +6.8% | +7.7% | +4.5% |
| ROCEReturn on capital employed | +2.4% | +11.5% | +5.7% | +9.3% | +10.1% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 7 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 1.66x | 0.22x | 0.60x | 0.43x | 0.19x | 2.60x |
| Net DebtTotal debt minus cash | $160M | $268M | $1.2B | $883M | $190M | $599.0B |
| Cash & Equiv.Liquid assets | $53M | $667M | $657M | $108M | $183M | $343.3B |
| Total DebtShort + long-term debt | $213M | $935M | $1.8B | $991M | $373M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 1.47x | 0.48x | 2.12x | 1.11x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,522 for CVBF. Over the past 12 months, WAFD leads with a +32.5% total return vs HOMB's +3.0%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs HOMB's 9.5% — a key indicator of consistent wealth creation.
| Metric | ||||||
|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | +2.7% | +17.1% | +14.8% | +9.3% | -0.5% |
| 1-Year ReturnPast 12 months | +14.5% | +3.0% | +32.5% | +16.3% | +11.1% | +21.8% |
| 3-Year ReturnCumulative with dividends | +50.9% | +31.2% | +37.6% | +64.4% | +59.7% | +138.2% |
| 5-Year ReturnCumulative with dividends | +18.2% | +22.1% | +29.5% | +15.2% | +35.1% | +118.2% |
| 10-Year ReturnCumulative with dividends | +25.8% | +57.7% | +91.9% | +66.9% | +101.5% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +9.5% | +11.2% | +18.0% | +16.9% | +33.6% |
Risk & Volatility
Evenly matched — PROV and WAFD each lead in 1 of 2 comparable metrics.
Risk & Volatility
PROV is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WAFD currently trades 99.9% from its 52-week high vs HOMB's 91.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.66x | 0.66x | 0.81x | 0.67x | 0.94x |
| 52-Week HighHighest price in past year | $17.42 | $30.83 | $37.10 | $21.48 | $69.83 | $337.25 |
| 52-Week LowLowest price in past year | $14.95 | $25.50 | $26.31 | $17.95 | $57.05 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +91.6% | +99.9% | +98.8% | +96.3% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 63.7 | 63.8 | 60.1 | 60.0 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 8K | 1.4M | 525K | 1.6M | 218K | 7.0M |
Analyst Outlook
Evenly matched — WAFD and CVBF each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PROV as "Hold", HOMB as "Hold", WAFD as "Hold", CVBF as "Hold", BANR as "Hold", JPM as "Buy". Consensus price targets imply 16.6% upside for CVBF (target: $25) vs -6.5% for PROV (target: $16). For income investors, CVBF offers the higher dividend yield at 3.85% vs JPM's 1.86%.
| Metric | ||||||
|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $16.00 | $31.50 | $35.00 | $24.75 | $64.25 | $339.75 |
| # AnalystsCovering analysts | 10 | 19 | 11 | 16 | 13 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +2.8% | +2.8% | +3.8% | +2.9% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 15 | 16 | 0 | 1 | 15 |
| Dividend / ShareAnnual DPS | $0.56 | $0.80 | $1.05 | $0.82 | $1.96 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +1.5% | +3.6% | +2.8% | +1.5% | +3.9% |
HOMB leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). JPM leads in 1 (Total Returns). 2 tied.
PROV vs HOMB vs WAFD vs CVBF vs BANR vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PROV or HOMB or WAFD or CVBF or BANR or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -5. 3% for Home Bancshares, Inc. (HOMB). Home Bancshares, Inc. (HOMB) offers the better valuation at 11. 7x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PROV or HOMB or WAFD or CVBF or BANR or JPM?
On trailing P/E, Home Bancshares, Inc.
(HOMB) is the cheapest at 11. 7x versus Provident Financial Holdings, Inc. at 18. 4x. On forward P/E, Banner Corporation is actually cheaper at 10. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus CVB Financial Corp. 's 4. 64x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PROV or HOMB or WAFD or CVBF or BANR or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +15. 2% for CVB Financial Corp. (CVBF). Over 10 years, the gap is even starker: JPM returned +465. 8% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PROV or HOMB or WAFD or CVBF or BANR or JPM?
By beta (market sensitivity over 5 years), Provident Financial Holdings, Inc.
(PROV) is the lower-risk stock at 0. 21β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 357% more volatile than PROV relative to the S&P 500. On balance sheet safety, Banner Corporation (BANR) carries a lower debt/equity ratio of 19% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — PROV or HOMB or WAFD or CVBF or BANR or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -5. 3% for Home Bancshares, Inc. (HOMB). On earnings-per-share growth, the picture is similar: Home Bancshares, Inc. grew EPS 19. 9% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PROV or HOMB or WAFD or CVBF or BANR or JPM?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 34. 6% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 34. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CVBF leads at 43. 8% versus 14. 8% for PROV. At the gross margin level — before operating expenses — CVBF leads at 79. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PROV or HOMB or WAFD or CVBF or BANR or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus CVB Financial Corp. 's 4. 64x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Banner Corporation (BANR) trades at 10. 9x forward P/E versus 15. 4x for Provident Financial Holdings, Inc. — 4. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVBF: 16. 6% to $24. 75.
08Which pays a better dividend — PROV or HOMB or WAFD or CVBF or BANR or JPM?
All stocks in this comparison pay dividends.
CVB Financial Corp. (CVBF) offers the highest yield at 3. 8%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is PROV or HOMB or WAFD or CVBF or BANR or JPM better for a retirement portfolio?
For long-horizon retirement investors, Provident Financial Holdings, Inc.
(PROV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 3% yield). Both have compounded well over 10 years (PROV: +25. 8%, CVBF: +66. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PROV and HOMB and WAFD and CVBF and BANR and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PROV is a small-cap income-oriented stock; HOMB is a small-cap deep-value stock; WAFD is a small-cap deep-value stock; CVBF is a small-cap deep-value stock; BANR is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.